
- This event has passed.
Cognitive Behavioral Nightmare Therapies and PTSD
September 18, 2024 @ 2:00 pm - 3:00 pm
Wednesday, September 18 at 2:00pm ET
The prevalence of nightmare disorder in the general population is 5%. Nightmares are typically characterized as idiopathic (i.e., from an unknown cause) or trauma-related (i.e., beginning or changing in frequency, severity, or content after a traumatic event). Nightmares are reported by 30% of trauma-exposed civilians, 50% of trauma-exposed veterans, and 30-40% of active duty military personnel and members of the National Guard. Among individuals diagnosed with PTSD, nightmare rates are higher and are reported by 57% of civilians with PTSD and 50-70% of active duty service members with PTSD. A variety of cognitive behavioral interventions show promise for the treatment of nightmares and also improve insomnia, PTSD, and depression. There is a wide range of names for the various treatments tested in randomized controlled trials, which creates challenges in comparing treatment efficacy by protocol in systematic reviews and meta-analyses. Furthermore, there are not enough providers trained in CBT-N. This presentation will bridge the gap by summarizing data regarding the definition and prevalence of nightmares, providing an overview of CBT-N protocols, describing research of the efficacy of CBT-N in PTSD, and describing a newly developed, DoD funded, web-based provider training for CBT-N.
About the Presenter
![]() of Texas Health Science Center at San Antonio. She is a licensed clinical psychologist and a Diplomat for Behavioral Sleep Medicine. Her work focuses on clinical research and supporting dissemination of evidence-based treatments for sleep disorders and PTSD with a focus on active duty military personnel in affiliation with the STRONG STAR Consortium. She has published more than 50 empirically- reviewed articles and is currently the PI of a DoD funded project to build and test a web-based provider training for CBT for nightmares and a DoD funded project comparing CBT-I and BBT-I in active duty service members with postconcussive symptoms following Mild TBI. |
![]() |